US Stock MarketDetailed Quotes

INAB In8bio

Watchlist
  • 0.867
  • +0.007+0.76%
Close Jul 17 16:00 ET
  • 0.860
  • -0.007-0.75%
Post 19:29 ET
38.23MMarket Cap-962P/E (TTM)

About In8bio Company

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.

Company Profile

SymbolINAB
Company NameIn8bio
Listing DateJul 30, 2021
Issue Price10.00
Founded2016
CEOMr. William Ho
MarketNASDAQ
Employees31
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address350 5th Avenue,Suite 5330
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10118
Phone1-646-600-6438

Company Executives

  • Name
  • Position
  • Salary
  • William Ho
  • Director, President and Chief Executive Officer
  • 1.85M
  • Patrick McCall
  • Principal Accounting Officer, Chief Financial Officer and Secretary
  • 914.84K
  • Dr. Kate Rochlin, PhD
  • Chief Operating Officer
  • --
  • Dr. Trishna Goswami, M.D.
  • Chief Medical Officer
  • 1.07M
  • Dr. Lawrence Lamb, PhD
  • Executive Vice President and Chief Scientific Officer
  • --
  • Alan S. Roemer
  • Chairman of the Board
  • 256.42K
  • Dr. Jeremy Graff, PhD
  • Director
  • 211.18K
  • Dr. Corinne Epperly, PhD
  • Director
  • 48.87K
  • Emily Wang Fairbairn
  • Independent Director
  • 172.92K
  • Peter C. Brandt
  • Independent Director
  • 195.42K
  • Luba Greenwood
  • Independent Director
  • 181.42K
  • Travis Whitfill
  • Independent Director
  • 163.67K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg